Literature DB >> 9802753

Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici.

D Fedele1, C Coscelli, F Santeusanio, A Bortolotti, L Chatenoud, E Colli, M Landoni, F Parazzini.   

Abstract

OBJECTIVE: Our objective was to analyze the prevalence and risk factors for erectile dysfunction (ED) in men with diabetes in Italy in a cross-sectional study. RESEARCH DESIGN AND METHODS: Eligible for the study were men aged 20-69 years with a diagnosis of IDDM or NIDDM who were observed on randomly selected days in 178 diabetes centers in Italy. ED was defined as a failure to achieve and maintain an erection sufficient for satisfactory sexual performance.
RESULTS: Of the 9,868 diabetic men interviewed, 3,534 (35.8%) reported ED. The prevalence increased with age, from 4.6% in men aged 20-29 to 45.5% in those aged > or =60 years (test for trend, P = 0.0001). After taking into account the confounding role of age, men with NIDDM reported ED less frequently than did men with IDDM (odds ratio [OR], 0.7; 95% CI 0.6-0.8). In comparison with men reporting diabetes lasting < or =5 years, the ORs for ED were 1.3 and 2.0 for subjects with diabetes lasting 6-10 and 11-30 years, respectively. In comparison with men with good metabolic control, the ORs for ED were 1.7 and 2.3 in men with fair and poor control, respectively. A history of diabetes-related arterial, retinal, or renal diseases and neuropathy was associated with an increased risk of ED. Finally, in comparison with never-smokers, the ORs for ED were 1.5 (95% CI 1.3-1.6) for current smokers and 1.4 (95% CI 1.3-1.6) for ex-smokers. The OR increased with number of cigarettes smoked per day: in comparison with men smoking <12 cigarettes per day, the OR was 1.5 (95% CI 1.3-1.7) for those smoking > or =30 cigarettes day.
CONCLUSIONS: The study offers a quantitative estimate of the prevalence of ED and of its main risk factors in Italian men with diabetes.

Entities:  

Mesh:

Year:  1998        PMID: 9802753     DOI: 10.2337/diacare.21.11.1973

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  31 in total

1.  Are subjects with erectile dysfunction aware of their condition? Results from a retrospective study based on an Italian free-call information service.

Authors:  A Aversa; A M Isidori; D Gianfrilli; E A Greco; A Graziottin; G Zizzo; A Lenzi; A Fabbri
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

2.  Cardiovascular autonomic neuropathy, erectile dysfunction and lower urinary tract symptoms in men with type 1 diabetes: findings from the DCCT/EDIC.

Authors:  Rodica Pop-Busui; Jim Hotaling; Barbara H Braffett; Patricia A Cleary; Rodney L Dunn; Catherine L Martin; Alan M Jacobson; Hunter Wessells; Aruna V Sarma
Journal:  J Urol       Date:  2015-01-10       Impact factor: 7.450

3.  Men with diabetes may require more aggressive treatment for erectile dysfunction.

Authors:  T J Walsh; J M Hotaling; A Smith; C Saigal; H Wessells
Journal:  Int J Impot Res       Date:  2013-12-19       Impact factor: 2.896

4.  Four-year review of sildenafil citrate.

Authors:  Andrew R McCullough
Journal:  Rev Urol       Date:  2002

Review 5.  Diagnosis and treatment of diabetic autonomic neuropathy.

Authors:  D Ziegler
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

6.  Erectile dysfunction and its management in patients with diabetes mellitus.

Authors:  Giuseppe Defeudis; Daniele Gianfrilli; Chiara Di Emidio; Riccardo Pofi; Dario Tuccinardi; Andrea Palermo; Andrea Lenzi; Paolo Pozzilli
Journal:  Rev Endocr Metab Disord       Date:  2015-10-26       Impact factor: 6.514

7.  Erectile dysfunction in young men with type 1 diabetes.

Authors:  M I Maiorino; G Bellastella; E Della Volpe; O Casciano; L Scappaticcio; P Cirillo; D Giugliano; K Esposito
Journal:  Int J Impot Res       Date:  2016-09-22       Impact factor: 2.896

8.  Effects of the start time of glycemic control on erectile function in streptozotocin-induced diabetic rats.

Authors:  O Kwon; S Y Cho; J-S Paick; S W Kim
Journal:  Int J Impot Res       Date:  2016-09-22       Impact factor: 2.896

9.  The SUBITO-DE study: sexual dysfunction in newly diagnosed type 2 diabetes male patients.

Authors:  G Corona; C B Giorda; D Cucinotta; P Guida; E Nada
Journal:  J Endocrinol Invest       Date:  2013-05-20       Impact factor: 4.256

Review 10.  Diabetes, obesity and erectile dysfunction: field overview and research priorities.

Authors:  Kanchan Chitaley; Varant Kupelian; Leslee Subak; Hunter Wessells
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.